A Pilot Study of Working Women and Breast Cancer
2 other identifiers
observational
22
1 country
2
Brief Summary
The purpose of this research is to better understand the relationship between employment and breast cancer. Research is being conducted to understand how workplace factors influence breast cancer patients' ability to adhere to recommended cancer treatment and effectively recover from cancer. Investigators hope to use the findings from the study to help working breast cancer survivors make informed decisions about treatment and employment in collaboration with their employers and healthcare providers.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Nov 2013
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 26, 2013
CompletedFirst Posted
Study publicly available on registry
August 2, 2013
CompletedStudy Start
First participant enrolled
November 1, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2015
CompletedMay 27, 2015
May 1, 2015
1.4 years
July 26, 2013
May 26, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Guideline concordant breast cancer treatment as defined by National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology and oncologist assessments.
Differences in receipt of guideline-concordant breast cancer treatment between working poor and working non-poor survivors as explained by variations in occupation and work organization factors associated with each group of women. Guideline-concordant treatment will be informed by National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology and oncologist assessments.
6 months
Secondary Outcomes (3)
Breast cancer treatment adherence, including completion of prescribed chemotherapy regimens, prescribed radiation treatment regimen, and/or surgical follow-up appointments.
6 months
Satisfaction with breast cancer treatment decision-making
6 months
Quality of life
6 months
Study Arms (2)
Working Poor Survivors
Low Wage workers
Non-Working Poor Survivors
Higher-Wage Salary Workers
Eligibility Criteria
Women diagnosed with a new, primary breast cancer within 3 months of enrollment and who were employed at the time of diagnosis.
You may qualify if:
- Women age 18-65
- Working at least 20 hours per week
- Currently patients of the University of Kentucky Markey Cancer Center
- Are able to read, write, and communicate in English
- Have reliable telephone or Internet/Web access in or outside the home
You may not qualify if:
- Self-employed
- Unemployed
- Cognitively impaired
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Robin Vanderpoollead
- National Institute on Drug Abuse (NIDA)collaborator
Study Sites (2)
UK Center for Clinical and Translational Science
Lexington, Kentucky, 40536, United States
University of Kentucky Markey Cancer Center
Lexington, Kentucky, 40536, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Robin Vanderpool, DrPH
University of Kentucky
Study Design
- Study Type
- observational
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
July 26, 2013
First Posted
August 2, 2013
Study Start
November 1, 2013
Primary Completion
April 1, 2015
Study Completion
April 1, 2015
Last Updated
May 27, 2015
Record last verified: 2015-05